Pamina M. Gorbach, M.H.S., Dr.P.H.


Core Scientist, Combination Prevention Core



Pamina M. Gorbach, MHS, DrPH, is a behavioral epidemiologist whose research focuses on the behaviors involved in transmission and acquisition of sexually transmitted infections including HIV especially around substance use. Methodological expertise includes measurement at the sexual partnership level, and adherence and acceptability measures for new methods of HIV prevention including microbicides and pre-exposure prophylaxis and application of technologies for collecting behavioral data. She is a Professor at the University of California, Los Angeles in the Department of Epidemiology, Fielding School of Public Health and in the Division of Infectious Diseases, David Geffen School of Medicine. Dr. Gorbach serves as an investigator in the Adolescent Trials Network (ATN), the HIV Prevention Trials Network (HPTN), the MACS Behavioral Working Group, and Microbicides Trial Network (MTN). She is the PI with Dr. Steven Shoptaw as Co-PI of a large NIDA funded cohort in Los Angeles entitled “Minority MSM and Substance Cohort at UCLA Linking Infections Noting Effects” known as “M Study”. Dr. Gorbach heads a Fogarty supported training program for Cambodia entitled “UCLA/Cambodia HIV/AIDS Training Program in Data Management & Analysis” and has had ongoing research there for 18 years. Local research focuses on HIV and also involves two studies of HPV among MSM. Her global health experience includes Cambodia, Vietnam, Peru, Costa Rica, the Dominican Republic, Brazil, Mali, Malawi, South Africa, and Ghana.


Infectious Disease Fellow, STD/HIV Epidemiology, University of Washington, Seattle, WA

Dr.Ph., Maternal Child Health & Health Behavior, University of North Carolina, Chapel Hill, NC

M.H.S., International Health, Johns Hopkins University, Baltimore, MD

B.A., Latin American Studies, Brown University, Providence, RI

Research and Interests:

Sexual behavior measurement, acute HIV infection, HIV transmission dynamics, acceptability and adherence to biomedical methods of HIV prevention